Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Zoetis Inc (ZTS) is a leading drug manufacturers-specialty & generic business with stocks listed in the US. It opened the day at US$208.03 after a previous close of US$208.62. During the day the price has varied from a low of USD206.84 to a high of USD209.075. The latest price was USD208.51 (25 minute delay). Zoetis is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Zoetis
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Zoetis. Find the share by name or ticker symbol: ZTS. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Zoetis reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$208.62, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Zoetis, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Zoetis. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
What's in this guide?
Zoetis stock price (NYSE:ZTS)
Use our graph to track the performance of ZTS stocks over time.Zoetis shares at a glance
Information last updated 2021-10-22.
| Open | US$208.03 |
|---|---|
| High | US$209.075 |
| Low | US$206.84 |
| Close | US$208.51 |
| Previous close | US$208.62 |
| Change | US$-0.11 |
| Change % | -0.0527% |
| Volume | 979,765 |
Information last updated 2022-06-25.
| 52-week range | US$154.18 - US$248.4353 |
|---|---|
| 50-day moving average | US$169.9052 |
| 200-day moving average | US$197.6252 |
| Target price | US$236.9 |
| PE ratio | 40.0574 |
| Dividend yield | US$1.075 (0.8%) |
| Earnings per share (TTM) | US$4.359 |
Compare trading apps to buy Zoetis shares
1 - 7 of 7
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Zoetis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Zoetis price performance over time
Historical closes compared with the last close of $208.51
| 1 week (2022-06-21) | 28.70% |
|---|---|
| 1 month (2022-05-25) | 27.90% |
| 3 months (2022-03-28) | 10.11% |
| 1 year (2021-06-28) | 11.45% |
|---|---|
| 2 years (2020-06-26) | 57.18% |
| 3 years (2019-06-28) | 83.73% |
| 5 years (2017-06-28) | 231.23% |
Is Zoetis under- or over-valued?
Valuing Zoetis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zoetis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zoetis's P/E ratio
Zoetis's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, Zoetis shares trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Zoetis's PEG ratio
Zoetis's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9815. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zoetis's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Zoetis's EBITDA
Zoetis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.2 billion (£2.7 billion).
The EBITDA is a measure of a Zoetis's overall financial performance and is widely used to measure a its profitability.
Zoetis financials
| Revenue TTM | US$7.9 billion |
|---|---|
| Operating margin TTM | 36.05% |
| Gross profit TTM | US$5.5 billion |
| Return on assets TTM | 12.86% |
| Return on equity TTM | 47.31% |
| Profit margin | 26.27% |
| Book value | 9.885 |
| Market capitalisation | US$82.2 billion |
TTM: trailing 12 months
Zoetis's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zoetis.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Zoetis's total ESG risk score
Total ESG risk: 28.6
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zoetis's overall score of 28.6 (as at 01/01/2019) is nothing to write home about – landing it in it in the 49th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Zoetis is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Zoetis's environmental score
Environmental score: 2.72/100
Zoetis's environmental score of 2.72 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Zoetis is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Zoetis's social score
Social score: 13/100
Zoetis's social score of 13 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Zoetis is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Zoetis's governance score
Governance score: 8.87/100
Zoetis's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Zoetis is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Zoetis's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Zoetis scored a 1 out of 5 for controversy – the highest score possible, reflecting that Zoetis has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Zoetis Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 28.6 |
|---|---|
| Total ESG percentile | 49.38 |
| Environmental score | 2.72 |
| Environmental score percentile | 1 |
| Social score | 13 |
| Social score percentile | 1 |
| Governance score | 8.87 |
| Governance score percentile | 1 |
| Level of controversy | 1 |
Zoetis share dividends
Dividend payout ratio: 25.74% of net profits
Recently Zoetis has paid out, on average, around 25.74% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.8% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zoetis shareholders could enjoy a 0.8% return on their shares, in the form of dividend payments. In Zoetis's case, that would currently equate to about $1.075 per share.
While Zoetis's payout ratio might seem fairly standard, it's worth remembering that Zoetis may be investing much of the rest of its net profits in future growth.
Zoetis's most recent dividend payout was on 1 September 2022. The latest dividend was paid out to all shareholders who bought their shares by 20 July 2022 (the "ex-dividend date").
Zoetis share price volatility
Over the last 12 months, Zoetis's shares have ranged in value from as little as US$154.18 up to US$248.4353. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zoetis's is 0.7677. This would suggest that Zoetis's shares are less volatile than average (for this exchange).
Zoetis overview
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Zoetis in the news
Frequently asked questions
More guides on Finder
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium shares
Steps to owning and managing Leo lithium shares.
Ask an Expert
